
This retrospective study from Japan highlighted several key elements linked to a generalized pustular psoriasis diagnosis among individuals with psoriasis vulgaris.
Tim Smith joined the MJH Life Sciences team in 2022 and is currently an associate editor for HCPLive. He is also the executive producer of two podcasts: Skin of Color Savvy and The Medical Sisterhood. He graduated from UC Berkeley and worked in multimedia journalism as a staff writer prior to joining MJH. You can contact him at tsmith@mjhlifesciences.com.

This retrospective study from Japan highlighted several key elements linked to a generalized pustular psoriasis diagnosis among individuals with psoriasis vulgaris.

In a recent study, DLE patients responded well to topical niacinamide 2% and 4% as adjuvant therapy, with strong results and few side effects.

Recent phase 3 clinical trial data explains response patterns of rheumatoid arthritis patients to baracitinib.

New research has helped to validate a predictive design model created to identify those most at risk for developing fibromyalgia.

An interview segment with Armstrong in which she elaborates on some of the main points made from her presentation on psoriasis treatments.

Despite worldwide trend data, incidence trends for dermatomyositis do not show increases among the study population.